Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) shares saw strong trading volume on Monday . 212,388 shares traded hands during mid-day trading, an increase of 17% from the previous session’s volume of 181,559 shares.The stock last traded at $3.29 and had previously closed at $3.27.

Several equities research analysts have recently commented on the company. Rodman & Renshaw reissued a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research note on Saturday, May 14th. Zacks Investment Research raised Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $6.25 target price for the company in a research note on Wednesday, April 27th.

The company has a 50 day moving average price of $3.20 and a 200 day moving average price of $3.97. The company’s market capitalization is $13.27 million.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.